Next Article in Journal
Near Infrared Optical Visualization of Epidermal Growth Factor Receptors Levels in COLO205 Colorectal Cell Line, Orthotopic Tumor in Mice and Human Biopsies
Next Article in Special Issue
Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features
Previous Article in Journal
miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases
Previous Article in Special Issue
p38β, A Novel Regulatory Target of Pokemon in Hepatic Cells
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(7), 14659-14668; doi:10.3390/ijms140714659

TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer

Department of Transfusion, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China
Department of Clinical Laboratory, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China
Department of Clinical Laboratory, No. 202 Hospital, Shenyang 110003, Liaoning, China
Author to whom correspondence should be addressed.
Received: 28 March 2013 / Revised: 27 June 2013 / Accepted: 9 July 2013 / Published: 12 July 2013
(This article belongs to the Special Issue Molecular Bases of Cancer Research)
View Full-Text   |   Download PDF [1251 KB, uploaded 19 June 2014]   |  


Triple-negative breast cancer (TNBC) is characterized by the lack of immunohistochemical staining for estrogen receptors (ER), progesterone receptors (PR), and lack of overexpression or amplification of human epidermal growth factor receptor 2 (HER2). Our aim was to investigate the expression of transmembrane protease, serine 4 (TMPRSS4) in TNBC patients and its possible relationship to the outcome of the disease. A total of 72 TNBC patients and 109 non-TNBC patients who were diagnosed between 2003 and 2008 were enrolled in this study. Immunohistochemistry was used to compare the expression pattern of TMPRSS4 in TNBC and non-TNBC groups, and the prognostic significance was assessed by Kaplan-Meier analysis and Cox proportional hazards regression in TNBC patients. The rate of high expression of TMPRSS4 was significantly higher in TNBC group than that in non-TNBC group. High expression of TMPRSS4 was significantly correlated with lymph node metastasis, histological grade, and tumor size. TNBC patients with high TMPRSS4 expression showed the poorer overall survival (OS) and disease-free survival (DFS) than those patients with low TMPRSS4 expression. In multivariate analysis, only lymph node metastasis and TMPRSS4 expression were the independent prognostic factors for OS and DFS in TNBC. Our study provides evidence that TMPRSS4 expression is associated with lymph node metastasis, tumor size, and histological grade in TNBC patients, and also is an independent prognostic factor for TNBC. View Full-Text
Keywords: transmembrane protease; triple-negative breast cancer; prognosis; immunohistochemistry transmembrane protease; triple-negative breast cancer; prognosis; immunohistochemistry

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Cheng, D.; Kong, H.; Li, Y. TMPRSS4 as a Poor Prognostic Factor for Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2013, 14, 14659-14668.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top